Intrinsic differences in brain and spinal cord mitochondria: Implication for therapeutic interventions

Journal of Comparative Neurology

Volumn 474, Issue 4, 2004, Pages 524-534

  Sullivan, Patrick G ^a   Rabchevsky, Alexander G ^a   Keller, Jeffery N ^a   Lovell, Mark ^a   Sodhi, Ajeet ^b   Hart, Ronald P ^b   Scheff, Stephen W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

CNS; Mitochondrial physiology; Motor neurons; Reactive oxygen species

Indexed keywords

COMPLEMENTARY DNA; CYCLOPHILIN; CYCLOSPORIN A; CYTOCHROME B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN MITOCHONDRION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME SUBUNIT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE; MOTONEURON; NEOCORTEX; NERVOUS SYSTEM INJURY; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; WESTERN BLOTTING;

ALDEHYDES; ANIMALS; BLOTTING, WESTERN; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; LIPID PEROXIDATION; MALE; MITOCHONDRIA; OXIDATION-REDUCTION; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 2642532860     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20130     Document Type: Article

References (56)

1. Andreyev A, Fiskum G. 1999. Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain vs. liver. Cell Death Differ 6:825-832.
2. Andreyev AY, Fahy B, Fiskum G. 1998. Cytochrome c release from brain mitochondria is independent of the mitochondrial permeability transition. FEBS Lett 439:373-376.
3. Andrus PK, Fleck TJ, Gurney ME, Hall ED. 1998. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 71:2041-2048.
4. Azbill RD, Mu X, Bruce-Keller AJ, Mattson MP, Springer JE. 1997. Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 765:283-290.
5. Bautista J, Corpas R, Ramos R, Cremades O, Gutierrez JF, Alegre S. 2000. Brain mitochondrial complex I inactivation by oxidative modification. Biochem Biophys Res Commun 275:890-894.
6. Beal MF. 1995. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366.
7. Bowling AC, Beal MF. 1995. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 56:1151-1171.
8. Braughler JM, Hall ED. 1992. Involvement of lipid peroxidation in CNS injury. J Neurotrauma 9(Suppl 1):S1-S7.
9. Brustovetsky N, Dubinsky JM. 2000. Limitations of cyclosporin A inhibition of the permeability transition in CNS mitochondria. J Neurosci 20:8229-8237.
10. Brustovetsky N, Brustovetsky T, Jemmerson R, Dubinsky JM. 2002. Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J Neurochem 80:207-218.
11. Buki A, Okonkwo DO, Povlishock JT. 1999. Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. J Neurotrauma 16:511-521.
12. 2+) overload and ROS generation in spinal motor neurons in vitro. J Neurosci 20:240-250.
13. Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate, and neuronal degenerative disorders. Science 262:689-695.
14. Dugan LL, Sensi SL, Canzoniero LM, Handran SD, Rothman SM, Lin TS, Goldberg MP, Choi DW. 1995. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 15:6377-6388.
15. Faden AI, Demediuk P, Panter SS, Vink R. 1989. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800.
16. Finkel E. 2001. The mitochondrion: is it central to apoptosis? Science 292:624-626.
17. Friberg H, Connern C, Halestrap AP, Wieloch T. 1999. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J Neurochem 72:2488-2497.
18. Gabbita SP, Lovell MA, Markesbery WR. 1998. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem 71:2034-2040.
19. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-1775.
20. Halestrap AP, Davidson AM. 1990. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 268:153-160.
21. Halestrap AP, Woodfield KY, Connern CP. 1997. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 272:3346-3354.
22. Hall ED, Braughler JM, McCall JM. 1992. Antioxidant effects in brain and spinal cord injury. J Neurotrauma 9(Suppl 1):S165-S172.
23. Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME. 1998. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 53:66-77.
24. Hunot S, Flavell RA. 2001. Apoptosis: death of a monopoly? Science 292: 865-866.
25. 2+ induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. J Biol Chem 276:47524-47529.
26. 2+) induces permeability transition pore opening and release of proapoptotic peptides from neuronal mitochondria. J Biol Chem 276: 47524-47529.
27. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP. 1998. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18:687-697.
28. Keller JN, Huang FF, Zhu H, Yu J, Ho YS, Kindy TS. 2000. Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab 20:1467-1473.
29. Lai JC, Clark JB. 1979. Preparation of synaptic and nonsynaptic mitochondria from mammalian brain. Methods Enzymol 55:51-60.
30. Liang LP, Ho YS, Patel M. 2000. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 101:563-570.
31. Nicholls DG, Budd SL. 1998. Mitochondria and neuronal glutamate excitotoxicity. Biochim Biophys Acta 1366:97-112.
32. Okonkwo DO, Povlishock JT. 1999. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J Cereb Blood Flow Metab 19: 443-451.
33. Okonkwo DO, Buki A, Siman R, Povlishock JT. 1999. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 10:353-358.
34. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
35. Prehn JH. 1998. Mitochondrial transmembrane potential and free radical production in excitotoxic neurodegeneration. Naunyn Schmiedebergs Arch Pharmacol 357:316-322.
36. Rabchevsky AG, Fugaccia I, Sullivan PG, Scheff SW. 2001a. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma 18:513-522.
37. Rabchevsky AG, Fugaccia I, Sullivan PG, Scheff SW. 2001b. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma 18:513-522.
38. Rabchevsky AG, Fugaccia I, Sullivan PG, Blades DA, Scheff SW. 2002. Efficacy of methylprednisolone therapy for the injured rat spinal cord. J Neurosci Res 68:7-18.
39. Rabchevsky AG, Sullivan PG, Fugaccia I, Scheff SW. 2003. Creatine diet supplement for spinal cord injury: influences on functional recovery and tissue sparing in rats. J Neurotrauma 20:659-669.
40. Reynolds IJ, Hastings TG. 1995. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 15:3318-3327.
41. Ririe KM, Rasmussen RP, Wittwer CT. 1997. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 245:154-160.
42. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
43. Scanlon JM, Reynolds IJ. 1998. Effects of oxidants and glutamate receptor activation on mitochondrial membrane potential in rat forebrain neurons. J Neurochem 71:2392-2400.
44. Scheff SW, Sullivan PG. 1999. Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J Neurotrauma 16:783-792.
45. Sengpiel B, Preis E, Krieglstein J, Prehn JH. 1998. NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur J Neurosci 10:1903-1910.
46. 2+ pools. Proc Natl Acad Sci USA 100:6157-6162.
47. Sriram K, Shankar SK, Boyd MR, Ravindranath V. 1998. Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid-mediated neurodegeneration. J Neurosci 18:10287-10296.
48. Stout AK, Raphael HM, Kabterewucz BI, Klann E, Reynolds IJ. 1998. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neursci 1:366-373.
49. Sullivan PG, Keller JN, Mattson MP, Scheff SW. 1998. Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. J Neurotrauma 15:789-798.
50. Sullivan PG, Bruce-Keller AJ, Rabchevsky AG, Christakos S, Clair DK, Mattson MP, Scheff SW. 1999a. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci 19:6248-6256.
51. Sullivan PG, Thompson MB, Scheff SW. 1999b. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 160:226-234.
52. Sullivan PG, Geiger JD, Mattson MP, Scheff SW. 2000a. Dietary supplement creatine protects against traumatic brain injury. Ann Neurol 48:723-729.
53. Sullivan PG, Rabchevsky AG, Hicks RR, Gibson TR, Fletcher-Turner A, Scheff SW. 2000b. Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 101: 289-295.
54. Sullivan PG, Keller JN, Bussen WL, Scheff SW. 2002. Cytochrome c release and caspase activation after traumatic brain injury. Brain Res 949:88-96.
55. Sullivan PG, Dube C, Dorenbos KD, Steward O, Baram TZ. 2003. Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol 53:711-717.
56. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. 1997. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22:176-181.